science
plus
.abes.fr
|
explorer
À propos de :
Toner G.
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
foaf:Person
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Person
New Facet based on Instances of this Class
Attributs
Valeurs
type
Person
name
Toner G.
Toner Guy C.
Toner G. C.
Toner G.C.
familyName
Toner
Given name
G.
G.C.
G. C.
Guy C.
is
relates
of
http://hub.abes.fr/oup/periodical/annonc/2003/volume_14/issue_6/101093annoncmdg252/authorship/3
http://hub.abes.fr/oup/periodical/annonc/2002/volume_13/issue_2/101093annoncmdf021/authorship/3
http://hub.abes.fr/oup/periodical/jnci/2010/volume_102/issue_16/101093jncidjq245/authorship/14
http://hub.abes.fr/oup/periodical/annonc/1999/volume_10/issue_4/101023a1008317205955/authorship/19
http://hub.abes.fr/oup/periodical/annonc/1999/volume_10/issue_8/101023a1008353522601/authorship/4
http://hub.abes.fr/oup/periodical/annonc/2002/volume_13/issue_5/101093annoncmdf117/authorship/7
http://hub.abes.fr/oup/periodical/annonc/2002/volume_13/issue_11/101093annoncmdf305/authorship/7
http://hub.abes.fr/springer/periodical/11060/1989/volume_7/issue_1/B950E8DD0F783E09E053120B220A5DF5/authorship/1
is
Author
of
The blood-brain barrier and response of C.N.S. metastases to chemotherapy
Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia
Significant impairment of high-dose methotrexate clearance following vancomycin administration in the absence of overt renal impairment
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: Results of a phase I study
Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial
Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors
A case report of oxaliplatin extravasation
Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
